Want to join the conversation?
$TMO's Diagnostics and Healthcare end-market businesses performance in 3Q15 was pretty much similar to what it has seen in the 1H15 with growth in the low single digits. The key contributors in 3Q15 were its Clinical Diagnostics business and Healthcare market channel, which continue to grow well.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.